Literature DB >> 4275829

Human mixed leukocyte culture: identification of the proliferating lymphocyte subpopulation by sex chromosome markers.

H P Lohrmann, J Whang-Peng.   

Abstract

The nature of the cells which proliferate in response to allogeneic histoincompatible lymphocytes in human mixed leukocyte cultures (MLC) was investigated. Direct information on the differentiation of proliferating cells was obtained in an in vitro chimeric system with T- and B-cell sex chromosome markers. Highly purified T and B cells were prepared from the peripheral blood of three pairs of HL-A genotype identical, MLC-negative siblings of opposite sex by E-rosette sedimentation techniques. Recombined T and B cells of the siblings were stimulated with allogeneic cells, and karyotype analysis of proliferating cells performed. 96% of the proliferating cells were found to carry the sex chromosome marker of the respective T-cell population. These results indicate that proliferation in human MLCs is a feature of T cells.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4275829      PMCID: PMC2139712          DOI: 10.1084/jem.140.1.54

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  25 in total

Review 1.  Immunologic significance of in vitro lymphocyte responses.

Authors:  F Daguillard
Journal:  Med Clin North Am       Date:  1972-03       Impact factor: 5.456

2.  A lymphocyte-stimulating factor produced in vitro.

Authors:  J Gordon; L D MacLean
Journal:  Nature       Date:  1965-11-20       Impact factor: 49.962

3.  Binding of sheep red blood cells to a large population of human lymphocytes.

Authors:  W H Lay; N F Mendes; C Bianco; V Nussenzweig
Journal:  Nature       Date:  1971-04-23       Impact factor: 49.962

4.  Serotyping for homotransplantation. 18. Refinement of microdroplet lymphocyte cytotoxicity test.

Authors:  K K Mittal; M R Mickey; D P Singal; P I Terasaki
Journal:  Transplantation       Date:  1968-11       Impact factor: 4.939

5.  Role of monocytes in the mixed leukocyte culture reaction.

Authors:  J Gordon
Journal:  Proc Soc Exp Biol Med       Date:  1968-01

6.  The mixed leukocyte culture: a three component system.

Authors:  H N Rode; J Gordon
Journal:  J Immunol       Date:  1970-06       Impact factor: 5.422

7.  Cellular requirements for the mitotic response in allogeneic mixed leukocyte cultures.

Authors:  J J Twomey; O Sharkey; J A Brown; A H Laughter; P H Jordan
Journal:  J Immunol       Date:  1970-04       Impact factor: 5.422

8.  Lymphocyte transformation in vitro. 3. Mechanism of stimulation in the mixed lymphocyte culture.

Authors:  P T Schellekens; V P Eijsvoogel
Journal:  Clin Exp Immunol       Date:  1970-08       Impact factor: 4.330

9.  Lymphocyte reactivity in vitro. I. Cellular reconstitution of purified lymphocyte response.

Authors:  B J Alter; F H Bach
Journal:  Cell Immunol       Date:  1970-07       Impact factor: 4.868

10.  Origin of immunoreactive lymphocytes in rats.

Authors:  J M Johnston; D B Wilson
Journal:  Cell Immunol       Date:  1970-10       Impact factor: 4.868

View more
  4 in total

1.  Human mixed lymphocyte culture using separated lymphocyte populations.

Authors:  M R Potter; M Moore
Journal:  Immunology       Date:  1977-03       Impact factor: 7.397

2.  The Sézary syndrome: a malignant proliferation of helper T cells.

Authors:  S Broder; R L Edelson; M A Lutzner; D L Nelson; R P MacDermott; M E Durm; C K Goldman; B D Meade; T A Waldmann
Journal:  J Clin Invest       Date:  1976-12       Impact factor: 14.808

3.  Lymphocyte transformation induced by autologous cells. IV. Human T-lymphocyte proliferation induced by autologous or allogeneic non-T lymphocytes.

Authors:  M M Kuntz; J B Innes; M E Weksler
Journal:  J Exp Med       Date:  1976-05-01       Impact factor: 14.307

4.  Serum albumin is essential for in vitro growth of activated human lymphocytes.

Authors:  H Polet; H Spieker-Polet
Journal:  J Exp Med       Date:  1975-10-01       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.